Back To Top

Radiopharmaceutical Development and Testing

The pioneer in nuclear medicine, radiotherapy and a world leading laboratory in radiobiology, CNL is your best partner to advance your vision from concept to market.
Radiopharmaceutical Development and Testing

Pre-clinical and Supporting Services

A comprehensive suite of world-class radiobiological research laboratories, with CNL aligning to receive GLP recognition later this year.

Services encompass 225Ac processing to supply commercial and collaborative studies, radiochemistry, dosimetry, materials handling and waste management; technical, regulatory and support services to complete pre-clinical and toxicological in vitro and in vivo studies.  All available in one site, to fast-track your drug development program.

Radiobiology and Supporting Services

  • Histopathology and Clinical Pathology
  • Genotoxicity
  • Regenerative Medicine

CNL capabilities for the development of radiopharmaceuticals

Isotope Production

  • Th-229 / Ac-225 generator
  • Isotope quality optimisation
  • Materials processing

Radiopharmaceuticals optimisation

  • Broad range of isotopes handling
  • Separation chemistry
  • Radiolabelling optimisation

Radiopharmaceuticals Evaluation

  • Pre-clinical evaluation
  • Dosimetry
  • Combined therapies
  • Long-term investigations

Icon CNL

We are happy to discuss how our capabilities in health sciences can help you succeed.